These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 32198576

  • 1. Extramedullary Disease in Multiple Myeloma.
    Jagosky MH, Usmani SZ.
    Curr Hematol Malig Rep; 2020 Apr; 15(2):62-71. PubMed ID: 32198576
    [Abstract] [Full Text] [Related]

  • 2. Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients.
    Avivi I, Cohen YC, Suska A, Shragai T, Mikala G, Garderet L, Seny GM, Glickman S, Jayabalan DS, Niesvizky R, Gozzetti A, Wiśniewska-Piąty K, Waszczuk-Gajda A, Usnarska-Zubkiewicz L, Hus I, Guzicka R, Radocha J, Milunovic V, Davila J, Gentile M, Castillo JJ, Jurczyszyn A.
    Am J Hematol; 2019 Oct; 94(10):1132-1140. PubMed ID: 31334859
    [Abstract] [Full Text] [Related]

  • 3. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M.
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [Abstract] [Full Text] [Related]

  • 4. Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
    Gagelmann N, Eikema DJ, Koster L, Caillot D, Pioltelli P, Lleonart JB, Reményi P, Blaise D, Schaap N, Trneny M, Passweg J, Porras RP, Cahn JY, Musso M, Poiré X, Fenk R, Itälä-Remes M, Pavone V, Fouillard L, Maertens J, Bron D, Pouli A, Schroyens W, Schönland S, Garderet L, Yakoub-Agha I, Kröger N.
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2134-2142. PubMed ID: 31288095
    [Abstract] [Full Text] [Related]

  • 5. Extramedullary disease in multiple myeloma.
    Bansal R, Rakshit S, Kumar S.
    Blood Cancer J; 2021 Sep 29; 11(9):161. PubMed ID: 34588423
    [Abstract] [Full Text] [Related]

  • 6. Natural history of multiple myeloma with de novo del(17p).
    Lakshman A, Painuly U, Rajkumar SV, Ketterling RP, Kapoor P, Greipp PT, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Dispenzieri A, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Leung N, Go RS, Lin Y, Kourelis TV, Warsame R, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK.
    Blood Cancer J; 2019 Mar 07; 9(3):32. PubMed ID: 30846679
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
    Deng S, Xu Y, An G, Sui W, Zou D, Zhao Y, Qi J, Li F, Hao M, Qiu L.
    Clin Lymphoma Myeloma Leuk; 2015 May 07; 15(5):286-91. PubMed ID: 25640025
    [Abstract] [Full Text] [Related]

  • 9. Plasma cell leukemia: from biology to treatment.
    Jelinek T, Kryukov F, Rihova L, Hajek R.
    Eur J Haematol; 2015 Jul 07; 95(1):16-26. PubMed ID: 25778450
    [Abstract] [Full Text] [Related]

  • 10. Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma.
    Hose D, Rème T, Hielscher T, Moreaux J, Messner T, Seckinger A, Benner A, Shaughnessy JD, Barlogie B, Zhou Y, Hillengass J, Bertsch U, Neben K, Möhler T, Rossi JF, Jauch A, Klein B, Goldschmidt H.
    Haematologica; 2011 Jan 07; 96(1):87-95. PubMed ID: 20884712
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetic Abnormalities in Extramedullary Multiple Myeloma.
    McAvera R, Quinn J, Murphy P, Glavey S.
    Int J Mol Sci; 2023 Jul 09; 24(14):. PubMed ID: 37511018
    [Abstract] [Full Text] [Related]

  • 13. Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
    Weinstock M, Aljawai Y, Morgan EA, Laubach J, Gannon M, Roccaro AM, Varga C, Mitsiades CS, Paba-Prada C, Schlossman R, Munshi N, Anderson KC, Richardson PP, Weller E, Ghobrial IM.
    Br J Haematol; 2015 Jun 09; 169(6):851-8. PubMed ID: 25833301
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Extramedullary disease in multiple myeloma: a systematic literature review.
    Bladé J, Beksac M, Caers J, Jurczyszyn A, von Lilienfeld-Toal M, Moreau P, Rasche L, Rosiñol L, Usmani SZ, Zamagni E, Richardson P.
    Blood Cancer J; 2022 Mar 21; 12(3):45. PubMed ID: 35314675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma.
    Weinhold N, Kirn D, Seckinger A, Hielscher T, Granzow M, Bertsch U, Egerer G, Salwender H, Blau IW, Weisel K, Hillengass J, Raab MS, Hose D, Goldschmidt H, Jauch A.
    Haematologica; 2016 Mar 21; 101(3):e116-9. PubMed ID: 26611471
    [No Abstract] [Full Text] [Related]

  • 18. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.
    Fassas AB, Muwalla F, Berryman T, Benramdane R, Joseph L, Anaissie E, Sethi R, Desikan R, Siegel D, Badros A, Toor A, Zangari M, Morris C, Angtuaco E, Mathew S, Wilson C, Hough A, Harik S, Barlogie B, Tricot G.
    Br J Haematol; 2002 Apr 21; 117(1):103-8. PubMed ID: 11918539
    [Abstract] [Full Text] [Related]

  • 19. [Research Progress on Multiple Myeloma with Extramedullary Disease].
    Wang L, Zhang YZ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun 21; 24(3):945-8. PubMed ID: 27342539
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.